Practice Management News

Actively partnering with patients and families in care improves health outcomes, but may be challenging to implement; therefore, ACP offered four principles to solidify the role of patients and families in their care plans in its position paper recently published in Annals of Internal Medicine.

The Trump administration’s latest effort to reduce drug prices met with generally positive reviews from policy analysts, who also noted the difficult path ahead to put the plan into effect.

Legacy prescribing — prescribing drugs past their usual effective or recommended period — seemed prevalent in primary care, according to findings recently published in Annals of Family Medicine.

The FDA announced today, that due to a lack of sterility assurance, it is alerting health care professionals and patients not to use drug products intended to be sterile that are produced and distributed by Pharm D Solutions of Houston.

The FDA outlined details of a study today that it said might allow animal drug developers to conduct certain types of research without the use of dogs.

CMS recently proposed a new rule to relieve regulatory burdens, strengthen accountability, enhance program integrity and promote transparency, innovation and flexibility in the Medicaid and CHIP managed care regulatory framework, according to a press release.

At this week’s AMA Interim Meeting, delegates urged states to impose more robust reporting of relevant information to the National Instant Criminal Background Check System.

During the AMA Interim Meeting, delegates adopted several new policies on important emerging health care topics, including gender identity.

To address concerns that out-of-pocket costs for prescription drugs have reduced access to essential medications, delegates at the Interim Meeting of the AMA adopted a policy supporting in-person purchase and importation of prescription drugs from licensed pharmacies in Canada.

As Medicare Advantage gains traction over traditional Medicare, there are several important potential issues that demand oversight, according to a paper published in The New England Journal of Medicine.